These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 16722027

  • 1. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM, Rojas-Campos E, Martínez-Ramírez HR, Valera-González I, Medina M, Monteón F, Ruiz N, Becerra M, Palomeque MA, Cortés-Sanabria L.
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [Abstract] [Full Text] [Related]

  • 2. Does a high peritoneal transport rate reflect a state of chronic inflammation?
    Wang T, Heimbürger O, Cheng HH, Bergström J, Lindholm B.
    Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG, Holmes DL, Dennis RL.
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [Abstract] [Full Text] [Related]

  • 6. The influence of automated peritoneal dialysis on the decrease in residual renal function.
    Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F.
    Nephrol Dial Transplant; 1999 May; 14(5):1224-8. PubMed ID: 10344365
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A, Hylander B, Wretlind B.
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [Abstract] [Full Text] [Related]

  • 8. Automated peritoneal dialysis: a Spanish multicentre study.
    Rodríguez AM, Díaz NV, Cubillo LP, Plana JT, Riscos MA, Delgado RM, Herrera CM, Ribes EA, Molina FT, Heras MM, González AT, Cantón CG, Fernández AR, Laborda EB, Zurita MN, Girón FF, Santana PS.
    Nephrol Dial Transplant; 1998 Sep; 13(9):2335-40. PubMed ID: 9761518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Gao H, Lew SQ, Bosch JP.
    Am J Nephrol; 1999 Sep; 19(1):7-12. PubMed ID: 10085443
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
    Pecoits-Filho R, Carvalho MJ, Stenvinkel P, Lindholm B, Heimbürger O.
    Perit Dial Int; 2006 Oct; 26(1):53-63. PubMed ID: 16538876
    [Abstract] [Full Text] [Related]

  • 16. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M, Albrektsen GE, Widerøe TE, Nilsen TI, Romundstad P, Hallan S, Aasarød K, Laegreid IK, Oien C.
    Perit Dial Int; 2004 Oct; 24(6):571-9. PubMed ID: 15559487
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.